Reference:
1. Calabrese A, Santucci D, Landi R. et al. Radiomics MRI for lymph node status prediction in breast cancer patients: the state of art. Journal of Cancer Research and Clinical Oncology, 2021, 147.6: 1587-1597.
2. Caudle A. S, Cupp J. A. et Kuerer H. M. Management of axillary disease. Surgical Oncology Clinics, 2014, 23.3: 473-486.
3. Panda SK, Goel A, Nayak V. et al. Can preoperative ultrasonography and MRI replace sentinel lymph node biopsy in management of axilla in early breast cancer—a prospective study from a tertiary cancer center. Indian Journal of Surgical Oncology, 2019, 10.3: 483-488.
4. Baltzer P. A, Dietzel M, Burmeister H. P. et al. Application of MR mammography beyond local staging: is there a potential to accurately assess axillary lymph nodes? Evaluation of an extended protocol in an initial prospective study. American Journal of Roentgenology. 2011; 196.5: W641-W647.
5. Lucci A, McCall L. M, Beitsch, P.D. et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. Journal of Clinical Oncology, 2007, 25.24: 3657-3663.
6. Giuliano A. E, Ballman K. V, McCall L. et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. Jama, 2017, 318.10: 918-926.
7. Song D, Yang F, Zhang Y. et al. Dynamic contrast-enhanced MRI radiomics nomogram for predicting axillary lymph node metastasis in breast cancer. Cancer Imaging, 2022, 22.1: 1-13.
8. Yu Y, Tan Y, Xie, C. et al. Development and validation of a preoperative magnetic resonance imaging radiomics–based signature to predict axillary lymph node metastasis and disease-free survival in patients with early-stage breast cancer. JAMA network open, 2020, 3.12: e2028086-e2028086.
9. Shan Y. N, Xu W, Wang R. et al. A nomogram combined radiomics and kinetic curve pattern as imaging biomarker for detecting metastatic axillary lymph node in invasive breast cancer. Frontiers in oncology, 2020, 10: 1463.